Monthly Archives: January 2016

Orthopedic Surgeon Dr. Meredith Warner Talks Return-to-Work, Louisiana’s Opioid Crisis

Dr. Meredith Warner, MD, MBA, of Warner Orthopedics and Wellness in Baton Rouge, is a foot and ankle surgeon, pain specialist and Veteran who treats workers’ comp patients with a keen eye toward return to work. Louisiana Comp Blog sat down with Dr. Warner to discuss her work and the provider experience in Louisiana’s workers’ comp system. Read on to get Dr. Warner’s thoughts on why more education is needed on all sides.

In national news:

The latest piece in NPR/ProPublica’s ongoing “Insult to Injury” special series on workers’ comp focuses again on opt-out.

In neighboring news:

A new McClatchy investigation assesses the status of nuclear plant workers and the federal program that was meant to compensate them in the face of the latest federal rule change to determine eligibility.

In medical news:

An analysis of federal data from IMS Health has revealed that moving Vicodin and similar products from schedule III to the more restrictive schedule II on the federal controlled substances list was associated with 1.1 billion fewer tablets and 26.3 million fewer prescriptions for the drugs in the first year following the change.

In neighboring news:

U.S. Attorney John Parker of the Northern District of Texas announced charges against a several individuals linked to a pill mill scheme in Dallas.

In research news:

A study utilizing investment simulations for 17 publicly held companies with strong health or safety programs for employees suggests that employers that invest significantly in health and safety programming can outperform other companies in the marketplace.

In national news:

The U.S. Department of Labor issued new guidance on when companies including staffing agencies and contractors can be classified as “joint employers” and be held liable for labor violations and workers’ comp.

In healthcare news:

Compounding pharmacies have accused Express Scripts in a federal antitrust complaint of conspiring with other giant pharmacy benefit managers to squeeze them out of the market through an illegal boycott.

In corporate news:

Sedgwick recently announced that it has published “The Scene for 2016,” forecasting major industry trends employers and risk management professionals should watch for this year.